Cargando…
C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls
There is increasing evidence for the role of inflammation in schizophrenia, yet the stability of increased peripheral inflammation in acute psychosis and the degree to which peripheral inflammation relates to cortical thickness, a measure of the degree of neuropathology, are unknown. In independent...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192380/ https://www.ncbi.nlm.nih.gov/pubmed/30364161 http://dx.doi.org/10.3389/fimmu.2018.02230 |
_version_ | 1783363900998156288 |
---|---|
author | Jacomb, Isabella Stanton, Clive Vasudevan, Rohini Powell, Hugh O'Donnell, Maryanne Lenroot, Rhoshel Bruggemann, Jason Balzan, Ryan Galletly, Cherrie Liu, Dennis Weickert, Cynthia S. Weickert, Thomas W. |
author_facet | Jacomb, Isabella Stanton, Clive Vasudevan, Rohini Powell, Hugh O'Donnell, Maryanne Lenroot, Rhoshel Bruggemann, Jason Balzan, Ryan Galletly, Cherrie Liu, Dennis Weickert, Cynthia S. Weickert, Thomas W. |
author_sort | Jacomb, Isabella |
collection | PubMed |
description | There is increasing evidence for the role of inflammation in schizophrenia, yet the stability of increased peripheral inflammation in acute psychosis and the degree to which peripheral inflammation relates to cortical thickness, a measure of the degree of neuropathology, are unknown. In independent samples, we assessed the peripheral inflammation marker C-reactive protein (CRP) to determine the extent to which: (1) CRP was elevated and stable across admissions for acute psychosis, (2) cognition, daily function and symptom severity are characteristic of chronically ill patients with schizophrenia displaying elevated CRP, and (3) CRP levels predict cortical thickness. Study 1 assessed peripheral CRP (primary outcome) and other blood measures in 174/280 people with acute psychosis while Study 2 assessed peripheral CRP, cognition and cortical thickness (primary outcomes), symptoms, and daily function in 85/97 chronically ill patients with schizophrenia and 71/87 healthy controls. In acute psychosis, CRP and neutrophil-to-lymphocyte ratio were significantly elevated relative to a normal cutoff (with 59.8% of patients having elevated CRP) which remained elevated across admissions. CRP was significantly elevated in 43% of chronically ill patients with schizophrenia compared to 20% in controls. Elevated CRP patients displayed significantly worse working memory and CRP was inversely correlated with cortical thickness in frontal, insula, and temporal brain regions. This work supports the role of inflammation in psychotic illnesses and suggests that use of peripheral markers (e.g., CRP) in conjunction with diagnosis could be used to identify patients with more cortical neuropathology and cognitive deficits. |
format | Online Article Text |
id | pubmed-6192380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61923802018-10-24 C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls Jacomb, Isabella Stanton, Clive Vasudevan, Rohini Powell, Hugh O'Donnell, Maryanne Lenroot, Rhoshel Bruggemann, Jason Balzan, Ryan Galletly, Cherrie Liu, Dennis Weickert, Cynthia S. Weickert, Thomas W. Front Immunol Immunology There is increasing evidence for the role of inflammation in schizophrenia, yet the stability of increased peripheral inflammation in acute psychosis and the degree to which peripheral inflammation relates to cortical thickness, a measure of the degree of neuropathology, are unknown. In independent samples, we assessed the peripheral inflammation marker C-reactive protein (CRP) to determine the extent to which: (1) CRP was elevated and stable across admissions for acute psychosis, (2) cognition, daily function and symptom severity are characteristic of chronically ill patients with schizophrenia displaying elevated CRP, and (3) CRP levels predict cortical thickness. Study 1 assessed peripheral CRP (primary outcome) and other blood measures in 174/280 people with acute psychosis while Study 2 assessed peripheral CRP, cognition and cortical thickness (primary outcomes), symptoms, and daily function in 85/97 chronically ill patients with schizophrenia and 71/87 healthy controls. In acute psychosis, CRP and neutrophil-to-lymphocyte ratio were significantly elevated relative to a normal cutoff (with 59.8% of patients having elevated CRP) which remained elevated across admissions. CRP was significantly elevated in 43% of chronically ill patients with schizophrenia compared to 20% in controls. Elevated CRP patients displayed significantly worse working memory and CRP was inversely correlated with cortical thickness in frontal, insula, and temporal brain regions. This work supports the role of inflammation in psychotic illnesses and suggests that use of peripheral markers (e.g., CRP) in conjunction with diagnosis could be used to identify patients with more cortical neuropathology and cognitive deficits. Frontiers Media S.A. 2018-10-10 /pmc/articles/PMC6192380/ /pubmed/30364161 http://dx.doi.org/10.3389/fimmu.2018.02230 Text en Copyright © 2018 Jacomb, Stanton, Vasudevan, Powell, O'Donnell, Lenroot, Bruggemann, Balzan, Galletly, Liu, Weickert and Weickert. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Jacomb, Isabella Stanton, Clive Vasudevan, Rohini Powell, Hugh O'Donnell, Maryanne Lenroot, Rhoshel Bruggemann, Jason Balzan, Ryan Galletly, Cherrie Liu, Dennis Weickert, Cynthia S. Weickert, Thomas W. C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls |
title | C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls |
title_full | C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls |
title_fullStr | C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls |
title_full_unstemmed | C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls |
title_short | C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls |
title_sort | c-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192380/ https://www.ncbi.nlm.nih.gov/pubmed/30364161 http://dx.doi.org/10.3389/fimmu.2018.02230 |
work_keys_str_mv | AT jacombisabella creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT stantonclive creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT vasudevanrohini creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT powellhugh creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT odonnellmaryanne creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT lenrootrhoshel creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT bruggemannjason creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT balzanryan creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT galletlycherrie creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT liudennis creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT weickertcynthias creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols AT weickertthomasw creactiveproteinhigherduringacutepsychoticepisodesandrelatedtocorticalthicknessinschizophreniaandhealthycontrols |